Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.62 |
| ▸ | SLC1A3 | P43003 | 4/20 | 0.50 |
| ▸ | SLC1A2 | P43004 | 4/20 | 0.50 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.50 |
| ▸ | GRIK1 | P39086 | 10/20 | 0.47 |
| ▸ | GRIK2 | Q13002 | 5/20 | 0.47 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.47 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.47 |
| ▸ | GRIA4 | P48058 | 3/20 | 0.44 |
| ▸ | GRIK3 | Q13003 | 3/20 | 0.44 |
| ▸ | GRIK5 | Q16478 | 3/20 | 0.44 |
| ▸ | GRIA2 | P42262 | 2/20 | 0.44 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Asparagine SCHEMBL8487870 | 1.00 | SLC7A5 (0.62) | SLC7A5SLC1A3SLC1A2SLC1A1GRIK1 | |
| Asparagine SCHEMBL8712670 | 1.00 | SLC7A5 (0.62) | SLC7A5SLC1A3SLC1A2SLC1A1GRIK1 | |
| Asparagine SCHEMBL8487875 | 1.00 | SLC7A5 (0.62) | SLC7A5SLC1A3SLC1A2SLC1A1GRIK1 | |
| Asparagine SCHEMBL8712672 | 1.00 | SLC7A5 (0.62) | SLC7A5SLC1A3SLC1A2SLC1A1GRIK1 | |
| Asparagine SCHEMBL8892690 | 0.96 | SLC7A5 (0.58) | SLC7A5SLC1A3SLC1A2SLC1A1GRIK1 | |
| Asparagine SCHEMBL8892693 | 0.96 | SLC7A5 (0.58) | SLC7A5SLC1A3SLC1A2SLC1A1GRIK1 | |
| Asparagine SCHEMBL18614518 | 0.93 | SLC7A5 (0.54) | SLC7A5SLC1A3SLC1A2SLC1A1GRIK1 | |
| Asparagine SCHEMBL20913225 | 0.93 | SLC7A5 (0.54) | SLC7A5SLC1A3SLC1A2SLC1A1GRIK1 | |
| Asparagine SCHEMBL3443446 | 0.93 | SLC7A5 (0.54) | SLC7A5SLC1A3SLC1A2SLC1A1GRIK1 | |
| Leucine SCHEMBL27563977 | 0.93 | SLC7A5 (0.64) | SLC7A5SLC1A3SLC1A2SLC1A1GRIK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2464656-A1 | NOVEL PEPTIDE AND USE THEREOF | Ensoltek Co., Ltd. (KR) | 2012-06-20 | — | — | EP | claimed |
| WO-2011019123-A1 | NOVEL PEPTIDE AND USE THEREOF | ENSOLTEK CO., LTD. (KR) | 2011-02-17 | — | — | WO | claimed |
| WO-2024112480-A1 | TREATMENT REGIMENS AND METHODS OF USING QUERCETIN TO PREVENT AND/OR TREAT MUSCLE WASTING DISORDERS | UNIVERSITY OF SOUTH CAROLINA (US) | 2024-05-30 | — | — | WO | disclosed |
| CN-102954773-B | Charged particle micro imaging method | FEI 公司 | 2016-12-21 | — | — | CN | disclosed |
| WO-2012162856-A1 | CRYSTAL OF CYTOKINE RECEPTOR | NOVO NORDISK A/S (DK) | 2012-12-06 | — | — | WO | disclosed |
| US-20120190625-A1 | NOVEL PEPTIDE AND USE THEREOF | ENSOLTEK CO., LTD. (KR) | 2012-07-26 | — | — | US | disclosed |
| EP-2464656-A1 | NOVEL PEPTIDE AND USE THEREOF | Ensoltek Co., Ltd. (KR) | 2012-06-20 | — | — | EP | disclosed |
| WO-2011019123-A1 | NOVEL PEPTIDE AND USE THEREOF | ENSOLTEK CO., LTD. (KR) | 2011-02-17 | — | — | WO | disclosed |
| US-6794501-B2 | Colon cancer antigen panel | LUDWIG INSTITUTE FOR CANCER RESEARCH | 2004-09-21 | — | — | US | disclosed |
| US-6784164-B2 | ANTIBODY PROTEIN IS EXPRESSED BY STREPTOCOCCUS, CAN BE ELUTED FROM A CHROMATOGRAPHIC COLUMN, USE AS BACTERICIDES, CELL LINE THAT PRODUCES A MONOCLONAL ANTIBODY | THE ROCKEFELLER UNIVERSITY | 2004-08-31 | — | — | US | disclosed |
| US-6767719-B1 | ISOLATING AND EXPRESSING THESE NUCLEIC ACIDS AND PROTEINS, WHICH HAVE APPLICATION TO THE CONTROL OF CELL PROLIFERATION AND AGING, INCLUDING THE CONTROL OF AGE-RELATED DISEASES, SUCH AS CANCER | GERON CORPORATION | 2004-07-27 | — | — | US | disclosed |
| WO-2002046392-A2 | X RAY CRYSTAL STRUCTURES AT 5.5 A RESOLUTION OF FUNCTIONAL COMPLEXES OF THE BACTERIAL RIBOSOME CONTAINING TRANSFER RNA AND MODEL MESSENGER RNAS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2002-06-13 | — | — | WO | disclosed |
| US-6100071-A | ANTAGONISTS FOR ANTIPROLIFERATIVE AGENTS AND ANGIOGENESIS INHIBITORS; COMPOSED OF TYROSINE KINASE RECEPTOR-DERIVED IMMUNOGLOBULIN-LIKE DOMAINS 1, 2, AND 3 FROM THE FLT-1 RECEPTOR AND/OR THE KDR RECEPTOR | GENENTECH, INC. (US) | 2000-08-08 | — | — | US | disclosed |
| US-5955345-A | DNA SEQUENCES THAT CODE FOR PANCREATIC POLYPEPTIDE; FOR DIAGNOSIS OF AND SCREENING FOR INSULIN-DEPENDENT DIABETES; ANTIDIABETIC AGENTS | BAYER CORPORATION FORMERLY MOLECULAR DIAGNOSTICS INC. (US) | 1999-09-21 | — | — | US | disclosed |
| US-5952199-A | A PROTEIN THAT CONTAINS AN IMMUNOGLOBULIN-LIKE DOMAIN; ANTIPROLIFERATIVE/ANTITUMOR AGENTS, TREATMENT OF RHEUMATOID ARTHRITIS, PSORIASIS, DIABETIES, GLAUCOMA, MUSCULAR DISORDERS AND IMMUNE REJECTION OF EYE TRANSPLANTS | GENENTECH, INC. (US) | 1999-09-14 | — | — | US | disclosed |
| WO-1992001046-A1 | LACCASE PRODUCTION BY RECOMBINANT ORGANISMS | VALTION TEKNILLINEN TUTKIMUSKESKUS (FI) | 1992-01-23 | — | — | WO | disclosed |
| WO-1991004036-A1 | TREPONEMA HYODYSENTERIAE ANTIGENS HAVING A MOLECULAR WEIGHT OF 39kDa AND DNA ENCODING THEREFOR | ML TECHNOLOGY VENTURES, L.P. (US) | 1991-04-04 | — | — | WO | disclosed |
| EP-0302103-A4 | COLONY STIMULATING FACTORS HAVING REDUCED LEVELS OF CARBOHYDRATE. | APPLIED BIOTECHNOLOGY INC (US) | 1989-06-21 | — | — | EP | disclosed |
| EP-0302103-A1 | COLONY STIMULATING FACTORS HAVING REDUCED LEVELS OF CARBOHYDRATE | GENETICS INSTITUTE, INC. (US) | 1989-02-08 | — | — | EP | disclosed |
| WO-1988005786-A1 | COLONY STIMULATING FACTORS HAVING REDUCED LEVELS OF CARBOHYDRATE | GENETICS INSTITUTE, INC. (US) | 1988-08-11 | — | — | WO | disclosed |